TransMedics Receivables 2019-2025 | TMDX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

TransMedics receivables from 2019 to 2025. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

TransMedics receivables from 2019 to 2025. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$182B
Intuitive Surgical (ISRG)	$178.1B
Edwards Lifesciences (EW)	$47.2B
IDEXX Laboratories (IDXX)	$46.1B
Alcon (ALC)	$45.1B
DexCom (DXCM)	$35B
IQVIA Holdings (IQV)	$33.1B
Mettler-Toledo (MTD)	$26.3B
STERIS (STE)	$22.5B
Waters (WAT)	$18B
SONOVA HOLDING (SONVY)	$17.2B
Hologic (HOLX)	$14.7B
Sysmex ADR (SSMXY)	$10.6B
Penumbra (PEN)	$8.8B
Masimo (MASI)	$8.6B
Globus Medical (GMED)	$7.3B
Glaukos (GKOS)	$5.4B
Teleflex (TFX)	$5.1B
Integer Holdings (ITGR)	$3.8B
PROCEPT BioRobotics (PRCT)	$3B
LivaNova (LIVN)	$2.4B
Nihon Kohden (NHNKY)	$2B
Elekta AB (EKTAY)	$1.9B
Veracyte (VCYT)	$1.9B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Tandem Diabetes Care (TNDM)	$1.1B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Integra LifeSciences Holdings (IART)	$999M